Thallous chloride (TI-201) injection Curium
Thallous chloride (TI-201) injection Curium is a medicine authorised by Swissmedic under authorisation number 44065. The authorisation holder is b.e.imaging.ag. The medicinal product code is Radiopharmaceuticals and the dispensing category is A: Supplied only against a medical or veterinary prescription that may not be dispensed repeatedly. First authorisation was granted on 11 December 1985 and the authorisation is valid without a time limit. ATC code V09GX01 places the medicine in the group Diagnostic radiopharmaceuticals.
| Authorisation number | 44065 |
|---|---|
| Name | Thallous chloride (TI-201) injection Curium |
| Full name | Thallous chloride (TI-201) injection Curium, Injektionslösung |
| Authorisation holder | b.e.imaging.ag |
| Medicinal product code | Radiopharmaceuticals |
| Dispensing category | A · Prescription, not repeatable |
| ATC code | V09GX01 |
| First authorisation | 11 December 1985 |
| Authorisation validity | unlimited |
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 1 | Thallous chloride (TI-201) injection Curium, Injektionslösung | A | 11 December 1985 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 1 | 85 | MBq | V09GX01 | 17.01.7. | A |
| 2 | 213 | MBq | V09GX01 | 17.01.7. | A |
| 3 | 370 | MBq | V09GX01 | 17.01.7. | A |
Scroll the table sideways
Other medicines from this authorisation holder
Frequently asked questions
Is Thallous chloride (TI-201) injection Curium authorised in Switzerland?
Yes. Thallous chloride (TI-201) injection Curium is authorised by Swissmedic under authorisation number 44065, data as of 01 September 2026. The authorisation is valid without a time limit.
Which dispensing category does Thallous chloride (TI-201) injection Curium have?
Thallous chloride (TI-201) injection Curium is in dispensing category A. Supplied only against a medical or veterinary prescription that may not be dispensed repeatedly.
Who is the authorisation holder of Thallous chloride (TI-201) injection Curium?
The authorisation holder is b.e.imaging.ag. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.